Andere talen 10x Genomics, Inc.

Aandelen

TXG

US88025U1097

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
29,28 ^USD	+3,10%		+6,16%	-47,68%

29/04	10X GENOMICS, INC. : Canaccord Genuity herhaalt koopadvies	ZM
18/04	10X GENOMICS, INC. : Deutsche Bank Securities bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Earnings Flash (TXG) 10X GENOMICS Reports Q1 Revenue $141M, vs. Street Est of $142.1M	22:45
10x Genomics: Q1 Earnings Snapshot	22:39
10x Genomics Reports First Quarter 2024 Financial Results	22:06
Petition Denied For Lacking Section 112(f) Construction And Fintiv	18/04
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?	17/04
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision	15/04
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	10/04
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision	29/03
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
10X Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform	14/03
10x Genomics Launches Two New Products With Single Cell Technology	13/03
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products	13/03
10x Genomics, Inc. Begins Commercial Shipments of Chromium GEM-X Products	13/03
Element Biosciences Announces Senior Vice President of Global Sales and Support	13/03
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference	20/02
10x Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
10x Genomics Q4 Net Loss Widens, Revenue Increases; Issues Outlook	15/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen 10x Genomics, Inc.

Aandelen

TXG

US88025U1097

Andere talen

Filters